LexaGene ’s New LX6 Rapid Pathogen Detection System: Interview with CEO Dr. Jack Regan
With the ever-growing list of potentially harmful pathogens being discovered, the systems needed to detect different strains need to become more sophisticated as well. Enter LexaGene, a biotechnology company developing automated and sensitive solutio...
Source: Medgadget - Category: Medical Devices Authors: Rukmani Sridharan Tags: Diagnostics Exclusive Pathology Public Health Source Type: blogs
More News: Biotechnology | Bird Flu | Brain | Cancer | Cancer & Oncology | Flu Pandemic | Genetics | Influenza | International Medicine & Public Health | Laboratory Medicine | Legislation | Medical Devices | Neurology | Pandemics | Pathology | Respiratory Medicine | Training | Universities & Medical Training